Guidance for 2026 is confirmed with strong order intake and sales acceleration expected. Margins are set to improve, supported by robust performance in food, beverage, and pharma, while capital allocation remains disciplined and the customer base diversified.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.